Drug Shortage Report for PDP-HYDROCODONE
Report ID | 180653 |
Drug Identification Number | 02324253 |
Brand name | PDP-HYDROCODONE |
Common or Proper name | PDP-HYDROCODONE |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCODONE BITARTRATE |
Strength(s) | 5MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL ORAL |
Packaging size | 500mL |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-06 |
Estimated end date | 2023-05-31 |
Actual end date | 2023-05-15 |
Shortage status | Resolved |
Updated date | 2023-05-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-05-16 | English | Compare |
v6 | 2023-05-15 | French | Compare |
v5 | 2023-05-15 | English | Compare |
v4 | 2023-04-12 | French | Compare |
v3 | 2023-04-12 | English | Compare |
v2 | 2023-01-11 | French | Compare |
v1 | 2023-01-11 | English | Compare |
Showing 1 to 7 of 7